A. Shehu

发表

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

M. Exline, Akram Khan, W. Self, 2022, BMJ.

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Samuel M. Brown, Manish M Patel, M. Exline, 2021, MMWR. Morbidity and mortality weekly report.

Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States

M. Exline, Akram Khan, W. Self, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients

M. Exline, Akram Khan, W. Self, 2022, The Journal of infectious diseases.

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021

Manish M Patel, M. Exline, Akram Khan, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States

Samuel M. Brown, Manish M Patel, H. Gershengorn, 2021, medRxiv.

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

M. Exline, Akram Khan, W. Self, 2021, JAMA.

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States

Samuel M. Brown, Manish M Patel, H. Gershengorn, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

Manish M Patel, H. Gershengorn, M. Exline, 2021, Clinical Infectious Diseases.

Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study

A. Monto, D. Hager, N. Shapiro, 2022, medRxiv.

Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States

M. Exline, Akram Khan, W. Self, 2022, Vaccine.

Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States

M. Exline, Akram Khan, W. Self, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Digital Commons

M. Exline, A. Ginde, A. Duggal, 2022 .

Digital Commons

M. Exline, A. Ginde, A. Duggal, 2022 .